Rex, your confusion I belive is that they are giving you two separate stats regarding SAE's. One regarding the total number of SAE's in leronlimab group vs placebo group (14% vs 39%) And another regarding the number of SAE's per pt per group (9% VS 21%). Hope this helps. Their format is not laid out well and is def not made for easy general public understanding.